The survey by polling institute Datafolha found that 22% of Brazilians said they would not be willing to take a COVID-19 vaccine, up from 9% in August.
The survey also found that 73% of respondents planned to take a photo and 5% said they were unsure if they would. These figures were 89% and 3% respectively in August.
President Jair Bolsonaro has expressed his doubt and opposition to the use of an inoculant to bring the COVID-19 pandemic under control.
Brazil has the third highest number of COVID-19 cases in the world, with more than 6.8 million infections since the start of the pandemic. More than 180,000 people have also died – the second highest death toll in the world after the United States.
Bolsonaro has been one of the most prominent COVID-19 skeptics among world leaders, repeatedly downplaying the severity of the virus, criticizing lockdowns and touting unproven cures.
In November, he said he would not take any COVID-19 vaccine that became available, while adding that it was his “right” to refuse.
Bolsonaro specifically expressed skepticism about the inoculant developed by Sinovac in China and produced in collaboration with the Butantan Institute of the State Government of Sao Paulo.
According to the Datafolha poll, only 47% of respondents said they would take a vaccine made in China, while 50% said they would not take it. Three percent said they were undecided.
The data also showed a correlation between rejection of a vaccine and confidence in Bolsonaro.
Thirty-three percent of people who said they always trust Bolsonaro also said they were unwilling to take the photo, compared to 16% who said they never trust him and are unwilling to take a photo. Photo.
Meanwhile, health experts recently decried Bolsonaro’s apparent attempts to assert control over the country’s independent health regulators, Anvisa, who they said could politicize vaccine approval.
On November 12, Bolsonaro appointed a retired soldier with no experience in medicine or vaccine development, Jorge Luiz Kormann, to fill one of five director posts of Anvisa.
Kormann would head a unit responsible for greenlighting vaccines.
If the Senate confirmed Kormann, Bolsonaro’s allies would occupy three of the health regulator’s five seats, giving them a majority in all agency decisions.